Tech Company Financing Transactions
Cerebral Therapeutics Funding Round
Cerebral Therapeutics closed a $35 million Series B funding round on 1/9/2020. Investors included RA Capital, Granite Point Capital and Perceptive Advisors.
Transaction Overview
Company Name
Announced On
1/9/2020
Transaction Type
Venture Equity
Amount
$35,000,000
Round
Series B
Investors
Proceeds Purpose
The Company plans to use Series B proceeds to conduct an international Phase 2b double-blind, randomized, placebo-controlled clinical trial of its proprietary investigational product candidate (CT-010) for the treatment of uncontrolled seizures in adults with medically refractory epilepsy.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
12635 E. Montview Blvd.
Aurora, CO 80010
USA
Aurora, CO 80010
USA
Phone
Website
Email Address
Not Recorded
Overview
Cerebral Therapeutics Inc. is a privately-held company founded with the goal of addressing the well-recognized limitations of existing treatments for uncontrolled neurological diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daniel Abrams
Chief Scientific Officer
Lisa Shafer
President
John Foster
VP - Bus. Development
Eric Distad
Browse more venture capital transactions:
Prev: 1/9/2020: Pieces Technologies venture capital transaction
Next: 1/9/2020: Alitheon venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs